● TIER 3 — Information onlyGRADE B-Nootropic / neuro peptides
Noopept (omberacetam, GVS-111)
Origin: Russia (Zakusov Institute). Citations verified: yes. 2 human study record(s) in the FitClinicMD studies database.
GOALS · Cognition
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Mechanism
N-phenylacetyl-L-prolylglycine ethyl ester (dipeptide-derived).
Human evidence · 2
Neznamov GG, Teleshova ES. Comparative studies of Noopept and piracetam... Neurosci Behav Physiol 2009.
Noopept in mild cognitive impairment in patients with stroke.
other/unspecifiedPMID 22500312 →
Reference only. This page summarizes publicly available regulatory and research information about Noopept (omberacetam, GVS-111). It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.